Literature DB >> 8749605

Consensus statement on predictive testing for Alzheimer disease.

H Brodaty1, M Conneally, S Gauthier, C Jennings, A Lennox, S Lovestone.   

Abstract

Entities:  

Keywords:  Alzheimer's Disease International; Genetics and Reproduction; Mental Health Therapies

Mesh：

Year:  1995        PMID： 8749605     DOI： 10.1097/00002093-199509040-00002

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  8 in total

Review 1.  Ethical, legal, and social dimensions of epilepsy genetics.

Authors:  Sara Shostak; Ruth Ottman
Journal:  Epilepsia       Date:  2006-10       Impact factor: 5.864

2.  A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.

Authors:  Winston W Chung; Clara A Chen; L Adrienne Cupples; J Scott Roberts; Susan C Hiraki; Anil K Nair; Robert C Green; Robert A Stern
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

3.  Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two Cases.

Authors:  Donna A Messner
Journal:  New Genet Soc       Date:  2011

4.  Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.

Authors:  Sato Ashida; Laura M Koehly; J Scott Roberts; Clara A Chen; Susan Hiraki; Robert C Green
Journal:  J Health Commun       Date:  2009-12

5.  Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.

Authors:  Susan Hiraki; Clara A Chen; J Scott Roberts; L Adrienne Cupples; Robert C Green
Journal:  J Genet Couns       Date:  2008-10-23       Impact factor: 2.537

6.  Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.

Authors:  Kurt D Christensen; J Scott Roberts; Wendy R Uhlmann; Robert C Green
Journal:  Genet Med       Date:  2011-05       Impact factor: 8.822

7.  Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.

Authors:  Katie Skeehan; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

8.  Evaluation of a Web-based decision aid for people considering the APOE genetic test for Alzheimer risk.

Authors:  Michael Ekstract; Golde I Holtzman; Kye Y Kim; Susan M Willis; Doris T Zallen
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.